Mark A. Cervinski, Ph.D. - Publications

Affiliations: 
2006 The University of North Dakota, Grand Forks, ND, United States 
Area:
Biochemistry

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Shajani-Yi Z, Lee HK, Cervinski MA. Hyponatremia, Hypokalemia, Hypochloremia, and Other Abnormalities. Clinical Chemistry. 62: 898. PMID 27235468 DOI: 10.1373/clinchem.2015.249292  0.44
2016 Cembrowski GS, Cervinski MA. Demystifying Reference Sample Quality Control. Clinical Chemistry. PMID 27197680 DOI: 10.1373/clinchem.2016.258129  0.44
2015 Tolan NV, Parnas ML, Baudhuin LM, Cervinski MA, Chan AS, Holmes DT, Horowitz G, Klee EW, Kumar RB, Master SR. "Big Data" in Laboratory Medicine. Clinical Chemistry. PMID 26487761 DOI: 10.1373/clinchem.2015.248591  0.44
2015 Cervinski MA, Lee HK, Martin IW, Gavrilov DK. A macro-enzyme cause of an isolated increase of alkaline phosphatase. Clinica Chimica Acta; International Journal of Clinical Chemistry. 440: 169-71. PMID 25463746 DOI: 10.1016/j.cca.2014.11.017  0.44
2014 Burchard PR, Abou Tayoun AN, Lefferts JA, Lewis LD, Tsongalis GJ, Cervinski MA. Development of a rapid clinical TPMT genotyping assay. Clinical Biochemistry. 47: 126-9. PMID 25093923 DOI: 10.1016/j.clinbiochem.2014.07.088  0.44
2014 Kelsey DE, Toher JL, Foster MT, Boulanger JA, Cervinski MA. Laboratory validation of a low density lipoprotein apolipoprotein-B assay. Clinical Biochemistry. 47: 211-5. PMID 25079242 DOI: 10.1016/j.clinbiochem.2014.07.016  0.44
2014 Cervinski MA. Laboratory analysis of intraosseous blood: bad to the bone? Clinical Chemistry and Laboratory Medicine. 52: e187-9. PMID 24636999 DOI: 10.1515/cclm-2014-0104  0.44
2014 Cervinski MA, Sam SS, Steinmetz HB, Wood B, Tsongalis GJ. Validation of interleukin 28B genotyping assay for clinical use. Clinical Biochemistry. 47: 478-80. PMID 24462832 DOI: 10.1016/j.clinbiochem.2014.01.009  0.44
2013 McCudden CR, Cervinski MA, Grenache DG, Haymond S, Korpi-Steiner N, Molinaro RJ, Saenger AK. The SYCL toolkit: creating a program within a professional organization for young scientists. Clinical Chemistry. 59: 1416-7. PMID 24137752 DOI: 10.1373/clinchem.2013.211011  0.44
2013 Cervinski MA, Schwab MC, Lefferts JA, Lewis LD, Lebel KA, Tyropolis AM, Pflueger SM, Tsongalis GJ. Establishment of a CYP2C19 genotyping assay for clinical use. American Journal of Clinical Pathology. 139: 202-7. PMID 23355205 DOI: 10.1309/AJCP9K2KDOCPCBSV  0.44
2012 Feix MK, Polito FA, Cervinski MA. A urine sample with an orange to red hue, what should we do? Clinical Chemistry. 58: 1497-8. PMID 23024130 DOI: 10.1373/clinchem.2012.187864  0.44
2010 Crimmins DL, Brada NA, Lockwood CM, Griest TA, Waldemer RJ, Cervinski MA, Ohlendorf MF, McQuillan JJ, Ladenson JH. ETRAP (efficient trapping and purification) of target protein polyclonal antibodies from GST-protein immune sera. Biotechnology and Applied Biochemistry. 57: 127-38. PMID 21054278 DOI: 10.1042/BA20100279  0.44
2010 Cervinski MA, Foster JD, Vaughan RA. Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression. Neuroscience. 170: 408-16. PMID 20643191 DOI: 10.1016/j.neuroscience.2010.07.025  0.44
2010 Bender L, Silverman LM, Dinulos MB, Nickel J, Grody WW. Direct-to-consumer genotyping: are we ready for a brave new world? Clinical Chemistry. 56: 1056-60. PMID 20511451 DOI: 10.1373/clinchem.2009.138743  0.44
2010 Cervinski MA, Gronowski AM. Reproductive-endocrine point-of-care testing: current status and limitations. Clinical Chemistry and Laboratory Medicine. 48: 935-42. PMID 20446758 DOI: 10.1515/CCLM.2010.183  0.44
2009 Cervinski MA, Lockwood CM, Ferguson AM, Odem RR, Stenman UH, Alfthan H, Grenache DG, Gronowski AM. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clinica Chimica Acta; International Journal of Clinical Chemistry. 406: 81-5. PMID 19477170 DOI: 10.1016/j.cca.2009.05.018  0.44
2009 Gronowski AM, Cervinski M, Stenman UH, Woodworth A, Ashby L, Scott MG. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Clinical Chemistry. 55: 1389-94. PMID 19395437 DOI: 10.1373/clinchem.2008.121210  0.44
2009 Cervinski MA, Duh SH, Hock KG, Gray J, Wei TQ, Kilgore DC, Christenson RH, Scott MG. Performance characteristics of a no-pretreatment, random access sirolimus assay for the Dimension RxL clinical chemistry system. Clinical Biochemistry. 42: 1123-7. PMID 19303402 DOI: 10.1016/j.clinbiochem.2009.03.009  0.44
2006 Foster JD, Cervinski MA, Gorentla BK, Vaughan RA. Regulation of the dopamine transporter by phosphorylation. Handbook of Experimental Pharmacology. 197-214. PMID 16722237 DOI: 10.1007/3-540-29784-7-10  0.44
2005 Cervinski MA, Foster JD, Vaughan RA. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms. The Journal of Biological Chemistry. 280: 40442-9. PMID 16204245 DOI: 10.1074/jbc.M501969200  0.44
2003 Foster JD, Pananusorn B, Cervinski MA, Holden HE, Vaughan RA. Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Brain Research. Molecular Brain Research. 110: 100-8. PMID 12573538 DOI: 10.1016/S0169-328X(02)00645-9  0.44
Show low-probability matches.